Publications by authors named "Arnoud van't Hof"

Objective: The gold standard imaging modality for assessing crural arterial disease is digital subtraction angiography (DSA). Using DSA, the operator can estimate the diameter and degree of stenosis and determine the diameter of the balloon. Since these measures are estimates, it allows for interobserver and intraobserver variability.

View Article and Find Full Text PDF

Introduction: Ischaemic heart disease is the single most common cause of death worldwide. Traditionally, distinguishing patients with cardiac ischaemia from patients with less alarming disease, in prehospital triage of chest pain, is challenging for both general practitioners and ambulance paramedics. Less than 20% of patients with chest pain, transferred to the emergency department (ED), have an acute coronary syndrome (ACS) and the transportation and analysis at the ED of non-ACS patients result in substantial healthcare costs and a great patient burden.

View Article and Find Full Text PDF
Article Synopsis
  • * A meta-analysis of 951 studies identified 19 relevant studies, revealing that patients at high to extreme risk saw a greater increase in Kansas City Cardiomyopathy Questionnaire (KCCQ) scores compared to intermediate risk patients.
  • * Although TAVI had a positive effect on HrQoL, the impact of frailty on post-TAVI outcomes showed mixed results between randomized and non-randomized studies, highlighting the need for further investigation.
View Article and Find Full Text PDF

Background: Patients scheduled for cardiac surgery and procedures often present with modifiable risk factors for adverse perioperative outcomes. Prehabilitation has shown potential to enhance mental and physical fitness; however, its effect on clinical cardiovascular endpoints in this population has not been studied.

Objectives: The current trial was designed to evaluate the effect of a personalized multimodal teleprehabilitation on the incidence of composite endpoint on major adverse cardiovascular events in patients scheduled for elective cardiac surgery.

View Article and Find Full Text PDF

Acute myocardial infarction still represents the major cause of mortality in high-income countries. Therefore, considerable efforts have been focused on the treatment of myocardial infarctions in the acute and long-term phase, with special attention being paid to reperfusion strategies and adjunctive antithrombotic therapies. In fact, despite the successful mechanical recanalization of the epicardial conduit, a substantial percentage of patients still experience poor myocardial reperfusion or acute/subacute in-stent thrombosis.

View Article and Find Full Text PDF
Article Synopsis
  • Major or life-threatening bleeding and stroke are complications that can occur after transcatheter aortic valve implantation (TAVI), impacting both mortality and quality of life (QoL).
  • Major bleeding increases the risk of death significantly, while minor bleeding does not affect mortality; however, both types of bleeding and stroke lead to lower mental QoL scores.
  • The study highlights that monitoring these complications is essential, as they correlate with poorer mental well-being in patients during the first year post-TAVI.
View Article and Find Full Text PDF
Article Synopsis
  • The 2023 European Society of Cardiology guidelines for acute coronary syndrome emphasize updated management strategies for better clinical outcomes.
  • The review highlights specific practices in the Netherlands, such as pre-treatment protocols and antiplatelet agent strategies tailored to patient needs.
  • It also covers the importance of risk scoring and the logistical aspects of scheduling coronary angiography to improve patient care efficiency.
View Article and Find Full Text PDF

Introduction: Cardiac rehabilitation programs face the challenge of suboptimal participation, despite being a level Ia recommendation. Cardiac telerehabilitation, with its potential to engage patients who might otherwise not show interest, necessitates the adaption of existing center-based cardiac rehabilitation programs to facilitate rehabilitation at home. REHAB + is a mobile cardiac telerehabilitation program cocreated with patients and rehabilitation centers, aiming to future-proof cardiac rehabilitation and improve accessibility.

View Article and Find Full Text PDF
Article Synopsis
  • * In a trial with 858 patients, results showed no significant difference in major complications between those who continued anticoagulation (16.5% experienced primary outcomes) and those who interrupted it (14.8%).
  • * Continuation of anticoagulation led to higher incidences of major bleeding (31.1% vs. 21.3%), suggesting that interrupting anticoagulation is safer in this patient population undergoing TAVI.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on improving the detection of periprocedural myocardial infarction (PMI) after coronary artery bypass grafting (CABG) by analyzing the changes in cardiac biomarker CK-MB over time.
  • It involved 635 patients with 1589 CK-MB measurements, where the majority showed no signs of PMI, pinpointing key factors like patient sex and surgical specifics that influence CK-MB levels.
  • A web-based application was developed to model CK-MB kinetics; the model achieved notable diagnostic accuracy, indicating its potential for wider use in monitoring and validating other cardiac biomarkers.
View Article and Find Full Text PDF

Objectives: Coronary revascularization is frequently performed for coronary artery disease (CAD). This study aims to assess the totality of randomized evidence comparing percutaneous coronary intervention with drug-eluting stents (DES-PCI) with coronary artery bypass grafting (CABG) for CAD.

Methods: A systematic search was applied to 3 electronic databases, including randomized trials comparing DES-PCI with CABG for CAD with 5-year follow-up.

View Article and Find Full Text PDF

Background: Fractional flow reserve (FFR) is an established method to guide decisions on revascularization; however, in patients with diabetes mellitus (DM), FFR-negative lesions carrying an optical coherence tomography-detected thin-cap fibroatheroma (TCFA) remain at high risk for adverse cardiac events.

Methods: In this prespecified subanalysis of the COMBINE OCT-FFR trial, DM patients with ≥1 FFR-negative, TCFA-positive medically treated target lesions referred to as vulnerable plaque (VP group), were compared to patients with exclusively FFR-positive target lesions who underwent complete revascularization (CR group). The primary endpoint was first and recurrent event analysis for target lesion failure and the secondary endpoint was a composite of cardiac death, target vessel myocardial infarction, target lesion revascularization, or hospitalization due to unstable angina.

View Article and Find Full Text PDF

: Mitral regurgitation (MR) affects millions worldwide, necessitating timely intervention. There are significant clinical challenges in the conservative management of MR, leaving a knowledge gap regarding the impact of multidisciplinary decision-making on treatment outcomes. This study aimed to provide insights into the impact of multidisciplinary decision-making on the survival outcomes of MR patients, focusing on conservative approaches.

View Article and Find Full Text PDF

Objectives: Myocardial ischaemia following coronary artery bypass grafting (CABG) is a potentially devastating complication. Nevertheless, the incidence, aetiology and prognostic relevance of unplanned coronary angiography (uCAG) remain understudied. We aimed to investigate the prevalence and outcome of patients undergoing urgent, uCAG in the postoperative period following CABG.

View Article and Find Full Text PDF
Article Synopsis
  • The optimal management of patients with atrial fibrillation (AF) requiring oral anticoagulation (OAC) during percutaneous coronary intervention (PCI) is debated, with current guidelines suggesting a temporary triple therapy regimen that includes aspirin, which raises bleeding risks.
  • A new study, the WOEST-3 trial, seeks to compare a 30-day dual antiplatelet therapy (DAPT) strategy that temporarily omits OAC against guideline-directed therapy post-PCI for AF patients, aiming to reduce bleeding without sacrificing efficacy.
  • With a sample of 2,000 patients, the trial will evaluate the rates of major bleeding and adverse ischemic events, making it the first randomized controlled trial to explore the omission of OAC
View Article and Find Full Text PDF
Article Synopsis
  • In patients with STEMI, prehospital tirofiban showed promise in enhancing myocardial reperfusion, but its effect on disrupted myocardial infarction rates remains uncertain, especially with high-sensitivity cardiac troponin (hs-cTn) tests.!* -
  • The On-TIME 2 trial demonstrated that prehospital tirofiban was associated with a higher incidence of disrupted MI, occurring in 8% of the tirofiban group versus 4% in the placebo group, and the results remained significant even after adjustments for other factors.!* -
  • Importantly, none of the patients with disrupted MI died during a one-year follow-up, compared to a 2.6% mortality rate in patients without disrupted MI
View Article and Find Full Text PDF

Aims: The ability to be physically active is pivotal to the quality of life in elderly patients. This study aims to describe the association between exercise capacity and health-related quality of life (HRQoL), anxiety, and depression following an exercise-based cardiac rehabilitation (CR) programme in elderly cardiac patients.

Methods And Results: Patients aged ≥65 years with acute and chronic coronary syndrome or heart valve surgery were consecutively included from eight CR centres in seven European countries.

View Article and Find Full Text PDF

Prediction of bleeding risk in patients receiving antithrombotic treatment has been repeatedly attempted and resulted in multiple risk models. Risk stratification can be used to personalize antithrombotic treatment to reduce bleeding complications. Although these risk models are validated and incorporated in the current guidelines, the feasibility and effectivity in daily practice remains questionable.

View Article and Find Full Text PDF

Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/IIIa; integrin αIIbβ3) receptor inhibitors (GPIs), abciximab, eptifibatide, and tirofiban. The thrombocytopenia ranges from mild (50 000-100 000 platelets/μL), to severe (20 000 to <50 000/μL), to profound (<20 000/μL). Profound thrombocytopenia appears to occur in <1% of patients receiving their first course of therapy.

View Article and Find Full Text PDF

Objectives: The use of cerebral embolic protection (CEP) during transcatheter aortic valve implantation (TAVI) has been studied in several randomised trials. We aimed to perform a systematic review and Bayesian meta-analysis of randomised CEP trials, focusing on a clinically relevant reduction in disabling stroke.

Methods: A systematic search was applied to three electronic databases, including trials that randomised TAVI patients to CEP versus standard treatment.

View Article and Find Full Text PDF

The management of patients with suspected acute coronary syndrome, especially in prehospital settings, is challenging. This Special Report focuses on studies in emergency medical services concerning chest pain patients' triage and risk stratification. In addition, it emphasizes advancements in point-of-care cardiac troponin testing.

View Article and Find Full Text PDF

Aims: The role of coronary calcification on clinical outcomes among different revascularization strategies in patients presenting with acute coronary syndromes (ACSs) has been rarely investigated. The aim of this investigation is to evaluate the role of coronary calcification, detected by coronary angiography, in the whole spectrum of patients presenting with acute ACS.

Methods And Results: The present study was a post hoc analysis of the MATRIX programme.

View Article and Find Full Text PDF